LIGAND PHARMACEUTICALS INC — Director's Dealing 2015

Feb 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2015-02-10

Reporting Person: DeSilva Nishan M (VP, Corporate Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-10	Common Stock	S	2300.0	$56.34	Disposed	16359	Direct
2015-02-10	Common Stock	A	5923.0	$0.0	Acquired	22282	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-10	Employee Stock Option (right to buy)	$56.26	A	20873.0	Acquired	2025-02-10	Common Stock (20873)	Direct

Footnotes

F1: Shares sold to cover taxes on the vesting of restricted stock.

F2: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/10/15.